Analyst Suggests Buying Intuitive Surgical 'Aggressively on Any Pullbacks' (ISRG)
More News related to ISRG
- Intuitive Surgical (ISRG) Blows Out Street Estimates; Highlights from Q409 Conference Call
- Miller Tabak Upgrades Intuitive Surgical (ISRG) to Buy
- Emerging Stock Report Initiates Independent Research Coverage on Intuitive Surgical, Inc.
- Morning Movers 1/22: SOMX, LGN, STBK, PIP, WHRT, TRGL Higher; CRIS, DEAR, MBHI, ISR, AMD, ACHN Lower
- Brean Murray Raises PT on Intuitive Surgical (ISRG); Market Opportunity Remains Immense
More News related to Analyst Comments
- Morgan Stanley Says Buy Commodities on Recent Dip
- JPMorgan Close to Upgrading UAL, AMR, US Airways; Raises Estimates on UAL Following Traffic Results (UAUA, AMR, LCC, more)
- S&P Revises Credit Outlooks On BofA (BAC) and Citi (C) to Negative, Saying No More Free Govenment Handouts
- S&P Revises Outlook on Citigroup (C) from Stable to Negative
- Wedbush Maintains an 'Outperform' on Electronic Arts (ERTS); Lowers PT & Estimates
Brean Murray maintains a 'Buy' on Intuitive Surgical (Nasdaq: ISRG), price target $280.
Brean analyst says, "At $280.80, the stock is trading at 40x our FY10 EPS estimate of $7.03 and bumping up against our target price. The fundamentals, particularly the longer-term one, seem to be remaining intact, however, and thus we would argue for buying aggressively on any pullbacks in the stock."
To see all the upgrades/downgrades on shares of ISRG, visit our Analyst Ratings page.
Intuitive Surgical, Inc. (Intuitive Surgical) is engaged in the designing, manufacturing and marketing of the da Vinci Surgical Systems.
Related Categories
Analyst CommentsStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
